Patents Assigned to SynerK Inc.
  • Compositions and methods for inhibiting TIGIT gene expression
    Patent number: 11312963
    Abstract: Disclosed herein are compounds, compositions, and methods for decreasing TIGIT mRNA and protein expression. Such methods are useful to treat, prevent, or ameliorate TIGIT associated diseases, disorders, and conditions.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: April 26, 2022
    Assignee: SynerK Inc.
    Inventors: Weiwen Jiang, Jimmy X. Tang, Daqing Wang, Dong Yu